Search Results

There are 5922 results for: content related to: Pretreatment platelet reactivity contribution to residual, post-treatment platelet reactivity in prasugrel-treated and ticagrelor-treated patients

  1. You have free access to this content
    High on-treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta-analysis

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 6, June 2015, Pages: 931–942, G. Lemesle, G. Schurtz, C. Bauters and M. Hamon

    Version of Record online : 21 APR 2015, DOI: 10.1111/jth.12907

  2. You have full text access to this OnlineOpen article
    Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist

    Cardiovascular Therapeutics

    Volume 27, Issue 4, Winter 2009, Pages: 259–274, Steen Husted and J.J.J. Van Giezen

    Version of Record online : 10 JUL 2009, DOI: 10.1111/j.1755-5922.2009.00096.x

  3. Emerging Antiplatelet Therapy for Coronary Artery Disease and Acute Coronary Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 3, March 2012, Pages: 244–273, Kathleen A. Packard, Jennifer A. Campbell, Jon T. Knezevich and Estella M. Davis

    Version of Record online : 28 FEB 2012, DOI: 10.1002/j.1875-9114.2012.01021.x

  4. You have free access to this content
    Clinical implications of drug–drug interactions with P2Y12 receptor inhibitors

    Journal of Thrombosis and Haemostasis

    Volume 12, Issue 1, January 2014, Pages: 2–13, J. M. Siller-Matula, D. Trenk, S. Krähenbühl, A. D. Michelson and G. Delle-Karth

    Version of Record online : 9 JAN 2014, DOI: 10.1111/jth.12445

  5. Novel Antiplatelet Agent Ticagrelor in the Management of Acute Coronary Syndrome

    Journal of Interventional Cardiology

    Volume 24, Issue 3, June 2011, Pages: 199–207, RADHAKRISHNAN RAMARAJ, MOHAMMAD REZA MOVAHED and MEHRNOOSH HASHEMZADEH

    Version of Record online : 28 DEC 2010, DOI: 10.1111/j.1540-8183.2010.00613.x

  6. You have full text access to this OnlineOpen article
    “Real-World” comparison of prasugrel with ticagrelor in patients with acute coronary syndrome treated with percutaneous coronary intervention in the United States

    Catheterization and Cardiovascular Interventions

    Cynthia Larmore, Mark B. Effron, Cliff Molife, Mitch DeKoven, Yajun Zhu, Jingsong Lu, Swapna Karkare, Hsiao D. Lieu, Won Chan Lee and George W. Vetrovec

    Version of Record online : 18 NOV 2015, DOI: 10.1002/ccd.26279

  7. You have free access to this content
    A comparison of the pharmacological profiles of prasugrel and ticagrelor assessed by platelet aggregation, thrombus formation and haemostasis in rats

    British Journal of Pharmacology

    Volume 169, Issue 1, May 2013, Pages: 82–89, A Sugidachi, K Ohno, T Ogawa, JA Jakubowski, M Hashimoto and A Tomizawa

    Version of Record online : 12 APR 2013, DOI: 10.1111/bph.12108

  8. You have free access to this content
    Ticagrelor: Positive, negative and misunderstood properties as a new antiplatelet agent

    Clinical and Experimental Pharmacology and Physiology

    Volume 40, Issue 7, July 2013, Pages: 398–403, Jennifer B Steiner, Zhenbiao Wu and Jun Ren

    Version of Record online : 21 JUN 2013, DOI: 10.1111/1440-1681.12097

  9. Comparison of patient intake of ticagrelor, prasugrel, or clopidogrel on restoring platelet function by donor platelets

    Transfusion

    Volume 55, Issue 6, June 2015, Pages: 1320–1326, Gisela Scharbert, Leonore Wetzel, Waltraud C. Schrottmaier, Julia B. Kral, Thomas Weber and Alice Assinger

    Version of Record online : 15 JAN 2015, DOI: 10.1111/trf.12977

  10. Antiplatelet function variability in clopidogrel-treated patients: need for new antiplatelet agents

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 1, February 2012, Pages: 2–10, Thomas Höchtl, Iannis Tentzeris, Karsten Schrör and Kurt Huber

    Version of Record online : 10 AUG 2011, DOI: 10.1111/j.1472-8206.2011.00985.x

  11. You have full text access to this OnlineOpen article
    Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 10, October 2014, Pages: 1077–1090, Paul P. Dobesh and Julie H. Oestreich

    Version of Record online : 28 AUG 2014, DOI: 10.1002/phar.1477

  12. “Conversations in cardiology”: How do you pick the best antiplatelet drug—Clopidogrel, prasugrel, ticagrelor for your PCI patient?

    Catheterization and Cardiovascular Interventions

    Volume 79, Issue 2, 1 February 2012, Pages: 255–262, Morton J. Kern

    Version of Record online : 23 JAN 2012, DOI: 10.1002/ccd.24299

  13. You have free access to this content
    Novel Platelet ADP P2Y12 Inhibitors in the Treatment of Acute Coronary Syndrome

    Cardiovascular Therapeutics

    Volume 30, Issue 4, August 2012, Pages: e167–e173, Guang-Ming Tan, Yat-Yin Lam and Bryan P. Yan

    Version of Record online : 31 JUL 2011, DOI: 10.1111/j.1755-5922.2011.00262.x

  14. Effects of autologous platelet transfusion on platelet inhibition in ticagrelor- and clopidogrel-treated subjects

    Journal of Thrombosis and Haemostasis

    Accepted manuscript online: 22 SEP 2016, R. Teng, G. F. Carlson, S. Nylander and T. L. G. Andersson

    DOI: 10.1111/jth.13511

  15. You have free access to this content
    Antiplatelet therapy: new pharmacological agents and changing paradigms

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue s1, June 2013, Pages: 316–329, D. Capodanno, J. L. Ferreiro and D. J. Angiolillo

    Version of Record online : 30 JUN 2013, DOI: 10.1111/jth.12219

  16. Upstream clopidogrel, prasugrel, or ticagrelor for patients treated with primary angioplasty: Results of an angiographic randomized pilot study

    Catheterization and Cardiovascular Interventions

    Volume 87, Issue 7, June 2016, Pages: 1187–1193, José R. Mont'Alverne-Filho, Carlos R.M. Rodrigues-Sobrinho, Fernando Medeiros, Francisco C. Falcão, Joao L. Falcão, Rafael C. Silva, Kevin J. Croce, Jose C. Nicolau, Marco Valgimigli, Patrick W. Serruys and Pedro A. Lemos

    Version of Record online : 28 NOV 2015, DOI: 10.1002/ccd.26334

  17. Acute coronary syndromes, myocardial infarction, thrombectomy and vulnerable plaque

    Catheterization and Cardiovascular Interventions

    Volume 85, Issue S2, May 1, 2015, Pages: S1–S176,

    Version of Record online : 16 APR 2015, DOI: 10.1002/ccd.25910

  18. Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention

    Internal Medicine Journal

    Volume 46, Issue 5, May 2016, Pages: 559–565, M. B. Yudi, D. J. Clark, O. Farouque, D. Eccleston, N. Andrianopoulos, S. J. Duffy, A. Brennan, J. Lefkovits, J. Ramchand, T. Yip, E. Oqueli, C. M. Reid, A. E. Ajani and Melbourne Interventional Group

    Version of Record online : 11 MAY 2016, DOI: 10.1111/imj.13041

  19. Lack of clinically significant pharmacological interactions between ticagrelor and enoxaparin or unfractionated heparin in healthy subjects

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 6, December 2012, Pages: 704–711, R. Teng and K. Butler

    Version of Record online : 2 JUL 2012, DOI: 10.1111/j.1365-2710.2012.01367.x

  20. You have free access to this content
    Genetics of platelet inhibitor treatment

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 642–653, Dietmar Trenk and Willibald Hochholzer

    Version of Record online : 20 MAR 2014, DOI: 10.1111/bcp.12230